Corporate Tech Investors

Action Potential Venture Capital

Action Potential Venture Capital is a corporate venture capital group that makes strategic investments in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Action Potential is a strategic venture capital fund of GlaxoSmithKline managed by a small, dedicated team based in Cambridge, Massachusetts and Palo Alto, California. As a vehicle for venture investing, Action Potential is interested in high-return opportunities in therapeutic bioelectronic medicines and in the technologies that enable future bioelectronic medicines. Action Potential's fund invests off of GSK's balance sheet, and is effectively a $150M evergreen fund, able to lead investments into start-ups, is stage agnostic, and once invested, behaves like a traditional financial investor following on our investments and well-aligned with other institutional VCs around the board.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/19/2023

Transaction History

Our records indicate that Action Potential Venture Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Partner

Imran Eba

        

Partner

Juan-Pablo Mas

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Action Potential Venture Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

ACT | Actua

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary